Chair of Cancer Therapeutics
University of Edinburgh, UK
Use of orthotopic glioblastoma models, including from mice and from fresh patient-derived tumour specimens, to advance the discovery and delivery of novel drug combination therapies for brain cancer. Of particular interest is the use of imaging using a multimodal platform that allows both 2-photon fluorescence and coherent Raman imaging approaches to interrogate the involvement of the brain environment, including blood flow and tissue oxygenation, on tumour behaviour and drug response.
Existing collaborations relevant to drug delivery
Publications relevant to drug delivery
Email for contact details